Evidence map›Paper›PMID 32160521›Full record

ArticleStem cell reports2020

Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma.

Wen-Ying Liao, Chung-Chi Hsu, Tze-Sian Chan, Chia-Jui Yen, Wei-Yu Chen, Hung-Wei Pan, Kelvin K Tsai

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The roles of KLHL family members in human cancers.American journal of cancer research · 2022
    Review
  16. Review
  17. Article
  18. A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Wen-Ying LiaoGraduate Institute of Clinical Medicine, Wan Fang Hospital, Taipei Medical University, 250 Wuxing St., Xinyi, Taipei 11031, Taiwan; Laboratory of Advanced Molecular Therapeutics, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan.
Chung-Chi HsuGraduate Institute of Clinical Medicine, Wan Fang Hospital, Taipei Medical University, 250 Wuxing St., Xinyi, Taipei 11031, Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung City 84001, Taiwan.
Tze-Sian ChanLaboratory of Advanced Molecular Therapeutics, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; School of Medicine, College of Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; Integrative Therapy Center for Gastroenterologic Cancers, Taipei Medical University, Taipei 11031, Taiwan.
Chia-Jui YenDivision of Hemato-oncology, Department of Medicine, National Cheng-Kung University Hospital, Tainan 70403, Taiwan.
Wei-Yu ChenDepartment of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan.
Hung-Wei PanSchool of Medicine, College of Medicine, I-Shou University, Kaohsiung City 84001, Taiwan.
Kelvin K TsaiGraduate Institute of Clinical Medicine, Wan Fang Hospital, Taipei Medical University, 250 Wuxing St., Xinyi, Taipei 11031, Taiwan; Laboratory of Advanced Molecular Therapeutics, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan; Integrative Therapy Center for Gastroenterologic Cancers, Taipei Medical University, Taipei 11031, Taiwan; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan; National Institute of Cancer Research, National Health Research Institutes (NHRIs), Zhunan 35053, Taiwan. Electronic address: tsaik@tmu.edu.tw.
Wan Fang Hospital · TWI-Shou University · TWNational Cheng Kung University Hospital · TWNational Health Research Institutes · TWTaipei Medical University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various populations of cancer stem cells (CSCs) have been identified in hepatocellular carcinoma (HCC). Wnt signaling is variably activated in HCC and regulates CSCs and tumorigenesis. We explored cell-to-cell Wnt and stemness heterogeneity in HCC by labeling freshly isolated cancer cells with a Wnt-specific reporter, thereby identifying a small subset (0.4%-8.9%) of Wnt-activity

Indexed as

Disease ProgressionWnt Signaling PathwayAdaptor Proteins, Signal TransducingBiomarkers, TumorCarcinogenesisCarcinoma, HepatocellularCullin ProteinsDishevelled ProteinsEpistasis, GeneticGenetic TestingGreen Fluorescent ProteinsHep G2 CellsHumansLiver NeoplasmsNeoplastic Stem CellsNerve Tissue ProteinsAdaptor Proteins, Signal TransducingASPM protein, humanBiomarkers, TumorCullin ProteinsDishevelled ProteinsDVL1 protein, humanGreen Fluorescent ProteinsKLHL12 protein, humanNerve Tissue ProteinsASPMcancer stem cellsDishevelled-1hepatocellular carcinomaheterogeneityprognostic markerubiquitin ligaseWnt

Identifiers

PMID32160521
PMCPMC7066362
OpenAlexW3011372132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.